619
Views
12
CrossRef citations to date
0
Altmetric
Articles

Enhanced production of recombinant Staphylococcus simulans lysostaphin using medium engineering

, ORCID Icon, , & ORCID Icon

References

  • Chambers, H.F. The Changing Epidemiology of Staphylococcus aureus? Emerging Infect. Dis. 2001, 7, 178–182.
  • Brown, A.F.; Leech, J.M.; Rogers, T.R.; McLoughlin, R.M. Staphylococcus aureus Colonization: Modulation of Host Immune Response and Impact on Human Vaccine Design. Frontiers in Immunology 2014, 4, 1–20.
  • Climo, M.W.; Patron, R.L.; Goldstein, B.P.; Archer, G.L. Lysostaphin Treatment of Experimental Methicillin-Resistant Staphylococcus aureus Aortic Valve Endocarditis. Antimicrob. Agents Chemother. 1998, 42, 1355–1360.
  • Shaheen, M.; Tantary, H.A.; Su, N. A Treatise on Bovine Mastitis: Disease and Disease Economics, Etiological Basis, Risk Factors, Impact on Human Health, Therapeutic Management, Prevention and Control Strategy. Adv. Dairy Res. 2015, 4, 150.
  • Becker, S.C.; Roach, D.R.; Chauhan, V.S.; Shen, Y.; Foster-Frey, J.; Powell, A.M.; Bauchan, G.; Lease, R.A.; Mohammadi, H.; Harty, W.J. Triple-Acting Lytic Enzyme Treatment of Drug-Resistant and Intracellular Staphylococcus aureus. Sci. Rep. 2016, 6, 1–10.
  • Hathaway, H.; Ajuebor, J.; Stephens, L.; Coffey, A.; Potter, U.; Sutton, J.M.; Jenkins, A.T. Thermally Triggered Release of the Bacteriophage Endolysin CHAPK and the Bacteriocin Lysostaphin for the Control of Methicillin Resistant Staphylococcus aureus (MRSA). J. Control Release 2017, 245, 108–115.
  • Wittekind, M.; Schuch, R. Cell Wall Hydrolases and Antibiotics: Exploiting Synergy to Create Efficacious New Antimicrobial Treatments. Curr. Opin. Microbiol. 2016, 33, 18–24.
  • Kumar, J.K. Lysostaphin: An Antistaphylococcal Agent. Appl. Microbiol. Biotechnol. 2008, 80, 555–561.
  • Nithya, S.; Nimal, T.R.; Baranwal, G.; Suresh, M.K.; Anju, C.,P.; Anil Kumar, V.; Gopi Mohan, C.; Jayakumar, R.; Biswas, R. Preparation, Characterization and Efficacy of Lysostaphin-Chitosan Gel against Staphylococcus aureus. Int. J. Biol. Macromol. 2018, 110, 157–166.
  • Narasimhaswamy, N.; Bairy, I.; Shenoy, G.; Bairy, L. In Vitro Activity of Recombinant Lysostaphin in Combination with Linezolid, Vancomycin and Oxacillin against Methicillin-Resistant Staphylococcus aureus. Iran J. Microbiol. 2017, 9, 208–212.
  • Sabala, I.; Jagielska, E.; Bardelang, P.T.; Czapinska, H.; Dahms, S.O.; Sharpe, J.A.; James, R.; Than, M.E.; Thomas, N.R.; Bochtler, M. Crystal Structure of the Antimicrobial Peptidase Lysostaphin from Staphylococcus simulans. FEBS. J. 2014, 281, 4112–4122.
  • Grundling, A.; Schneewind, O. Cross-Linked Peptidoglycan Mediates Lysostaphin Binding to the Cell Wall Envelope of Staphylococcus aureus. J. Bacteriol. 2006, 188, 2463–2472.
  • Sharma, R.; Sharma, P.R.; Choudhary, M.L.; Pande, A.; Khatri, G.S. Cytoplasmic Expression of Mature Glycylglycine Endopeptidase Lysostaphin with an Amino Terminal Hexa-Histidine in a Soluble and Catalytically Active Form in Escherichia coli. Protein Expres. Purif. 2006, 45, 206–215.
  • Yeroslavsky, G.; Girshevitz, O.; Foster-Frey, J.; Donovan, D.M.; Rahimipour, S. Antibacterial and Antibiofilm Surfaces through Polydopamine-Assisted Immobilization of Lysostaphin as an Antibacterial Enzyme. Langmuir 2015, 31, 1064–1073.
  • Kokai-Kun, J.F.; Chanturiya, T.; Mond, J.J. Lysostaphin as a Treatment for Systemic Staphylococcus aureus Infection in a Mouse Model. J. Antimicrob. Chemother. 2007, 60, 1051–1059.
  • Johnson, C.T.; Wroe, J.A.; Agarwal, R.; Martin, K.E.; Guldberg, R.E.; Donlan, R.M.; Westblade, L.F.; Garcia, A.J. Hydrogel Delivery of Lysostaphin Eliminates Orthopedic Implant Infection by Staphylococcus aureus and Supports Fracture Healing. Proc. Natl. Acad. Sci. USA. 2018, 115, E4960–E4969.
  • Szweda, P.; Kotłowski, R.; Kur, J. New Effective Sources of the Staphylococcus simulans Lysostaphin. J. Biotechnol. 2005, 117, 203–213.
  • Kokai-Kun, J.F.; Chanturiya, T.; Mond, J.J. Lysostaphin Eradicates Established Staphylococcus aureus Biofilms in Jugular Vein Catheterized Mice. J. Antimicrob. Chemother. 2009, 64, 94–100.
  • Ceotto-Vigoder, H.; Marques, S.L.; Santos, I.N.; Alves, M.D.; Barrias, E.S.; Potter, A.; Alviano, D.S.; Bastos, M.C. Nisin and Lysostaphin Activity against Preformed Biofilm of Staphylococcus aureus Involved in Bovine Mastitis. J. Appl. Microbiol. 2016, 121, 101–114.
  • Hogan, S.; Zapotoczna, M.; Stevens, N.T.; Humphreys, H.; O'Gara, J.P.; O'Neill, E. Potential Use of Targeted Enzymatic Agents in the Treatment of Staphylococcus aureus Biofilm-Related Infections. J. Hosp. Infect. 2017, 96, 177–182.
  • Xue, B.; Zhang, C.; Wang, Y.; Wang, J.; Zhang, J.; Lu, M.; Li, G.; Cao, Z.; Huang, Q. A Novel Controlled-Release System for Antibacterial Enzyme Lysostaphin Delivery Using Hydroxyapatite/Chitosan Composite Bone Cement. PLoS One 2014, 9, e113797.
  • Recsei, P.A.; Gruss, A.D.; Novick, R.P. Cloning, Sequence, and Expression of the Lysostaphin Gene from Staphylococcus simulans. Proc. Natl. Acad. Sci. USA. 1987, 84, 1127–1131.
  • Williamson, C.M.; Bramley, A.J.; Lax, A.J. Expression of the Lysostaphin Gene of Staphylococcus simulans in a Eukaryotic System. Appl. Environ. Microbiol. 1994, 60, 771–776.
  • Gaier, W.; Vogel, R.F.; Hammes, W.P. Cloning and Expression of the Lysostaphin Gene in Bacillus subtilis and Lactobacillus casei. Lett. Appl. Microbiol. 1992, 14, 72–76.
  • Mierau, I.; Leij, P.; van Swam, I.; Blommestein, B.; Floris, E.; Mond, J.; Smid, E.J. Industrial-Scale Production and Purification of a Heterologous Protein in Lactococcus lactis Using the Nisin-Controlled Gene Expression System NICE: The Case of Lysostaphin. Microb. Cell. Fact. 2005, 4, 1–9.
  • Zhao, H.; Blazanovic, K.; Choi, Y.; Bailey-Kellogg, C.; Griswold, K.E. Gene and Protein Sequence Optimization for High-Level Production of Fully Active and Aglycosylated Lysostaphin in Pichia pastoris. Appl. Environ. Microbiol. 2014, 80, 2746–2753.
  • Saidijam, M.; Naderi, S.; Alikhani, M.; Karimi, J.; Shabab, N.; Mohamadi, N.; Jaliani, H. Cytoplasmic Expression, Optimization and Catalytic Activity Evaluation of Recombinant Mature Lysostaphin as an anti-Staphylococcal Therapeutic in Escherichia coli. Acta Medica Int. 2015, 2, 72–77
  • Boksha, I.S.; Lavrova, N.V.; Grishin, A.V.; Demidenko, A.V.; Lyashchuk, A.M.; Galushkina, Z.M.; Ovchinnikov, R.S.; Umyarov, A.M.; Avetisian, L.R.; Chernukha, M.I.; et al. Staphylococcus simulans Recombinant Lysostaphin: Production, Purification, and Determination of Antistaphylococcal Activity. Biochem. Moscow 2016, 81, 502–510.
  • Hemansi, Gupta, R.; Kuhad, R.C.; Saini, J.K. Cost Effective Production of Complete Cellulase System by Newly Isolated Aspergillus niger RCKH-3 for Efficient Enzymatic Saccharification: Medium Engineering by Overall Evaluation Criteria Approach (OEC). Biochem. Eng. J. 2018, 132, 182–190.
  • Studier, F.W. Protein Production by Auto-Induction in High Density Shaking Cultures. Protein Expres. Purif. 2005, 41, 207–234.
  • Laemmli, U.K. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4. Nature 1970, 227, 680–685.
  • Osma, J.F.; Toca-Herrera, J.L.; Rodriguez-Couto, S. Cost Analysis in Laccase Production. J. Env. Manag. 2011, 92, 2907–2912.
  • Fathi-Roudsari, M.; Maghsoudi, N.; Maghsoudi, A.; Niazi, S.; Soleiman, M. Auto-Induction for High Level Production of Biologically Active Reteplase in Escherichia coli. Protein Expres. Purif. 2018, 151, 18–22.
  • Ukkonen, K.; Mayer, S.; Vasala, A.; Neubauer, P. Use of Slow Glucose Feeding as Supporting Carbon Source in Lactose Autoinduction Medium Improves the Robustness of Protein Expression at Different Aeration Conditions. Protein Expres. Purif. 2013, 91, 147–154.
  • You, Z.; Zhang, S.; Liu, X.; Wang, Y. Enhancement of Prodigiosin Synthetase (PigC) Production from Recombinant Escherichia coli through Optimization of Induction Strategy and Media. Prep. Biochem. Biotechnol. 2018, 48, 226–233.
  • Sivashanmugam, A.; Murray, V.; Cui, C.; Zhang, Y.; Wang, J.; Li, Q. Practical Protocols for Production of Very High Yields of Recombinant Proteins Using Escherichia coli. Protein Sci. 2009, 18, 936–948.
  • Szweda, P.; Gorczyca, G.; Filipkowski, P.; Zalewska, M.; Milewski, S. Efficient Production of Staphylococcus simulans Lysostaphin in a Benchtop Bioreactor by Recombinant Escherichia coli. Prep. Biochem. Biotechnol. 2014, 44, 370–381.
  • Mierau, I. Nisin Controlled Gene Expression (NICE) in Lactococcus lactis Versatile Applications Ranging from Membrane Proteins to Large Scale Processes. Microbial Cell Factories 2006, 5, S39.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.